Summit Therapeutics Inc.Summit Therapeutics Inc.Summit Therapeutics Inc.

Summit Therapeutics Inc.

No trades
See on Supercharts

Price target

34.750.000.00%
The 4 analysts offering 1 year price forecasts for SMMT have a max estimate of — and a min estimate of —.

Analyst rating

Based on 4 analysts giving stock ratings to SMMT in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SMMT EPS for the last quarter is −0.05 USD despite the estimation of −0.07 USD. In the next quarter EPS is expected to reach −0.08 USD. Track more of Summit Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Summit Therapeutics Inc. revenue is expected to reach 0.00 USD. Check out Summit Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, SMMT price target is 34.75 USD with a max estimate of 44.00 USD and a min estimate of 23.00 USD. Check if this forecast comes true in a year, meanwhile watch Summit Therapeutics Inc. stock price chart and keep track of the current situation with SMMT news and stock market news.